Authors
Latest:
Virtual Trials Save the DayVirtual trials tools are usually selected early in the protocol development stage, however, due to the COVID-19 crisis, regulators are encouraging sponsors to consider integrating virtual elements into clinical trials already in progress.
Latest:
Steps Toward Diversity in Clinical Trials: Building Authentic TrustBuilding authentic trust lays at the heart of creating more patient-centric trials.
Latest:
Harnessing the Power of Scientific SurveillanceStatistical methods used via this technique in centralized monitoring.
Latest:
A Cross-Sectional Study of Patient Perspectives on Clinical Trial Participation in a Large Community-Based Research FacilityAn overview of patient perceptions of cancer clinical trials and the consent process among those who are currently enrolled in, or who recently completed, a cancer clinical trial.
Latest:
Impact of COVID-19 on Phase I Clinical ActivitiesLife sciences companies challenged by need to minimize health risks without sacrificing data quality during pandemic.
Latest:
COVID-19 Will Have a Heterogeneous Impact on Clinical Trials, BiopharmasA discussion of how the coronavirus pandemic will have a multitude of impacts on the conduct of trials, as well as on the industry itself.
Latest:
Remembering That TIME Magazine Issue; Celebrating Progress in Patient EngagementLooking to the past reminds industry of great strides taken in clinical research for patients.
Latest:
eSource Interoperability Between EHR and EDCEvidence from a Phase III cancer trial points to notable advances in data-transfer tech.
Latest:
How to Determine ‘Good Science’ for Systematic Literature Reviews in Clinical Research and DevelopmentBest practices for assessing publications.
Latest:
Using Machine Learning to Predict Placebo Response and Increase Clinical Trial SuccessA look at the prevalence of placebo response in clinical trials and how advanced solutions can mitigate the risk it poses to drug development.
Latest:
Aligning Patient Burden with Planetary BurdenHow making trial participation easier can reduce the impact on the environment.
Latest:
How DCT Technology Can Enable Follow-up Clinical StudiesResearch can reveal vital information about treatments in the long run.
Latest:
Improving Diversity in Clinical Trial Volunteer Participation by Addressing Racial and Ethnic Representation Among the Clinical Research Workforce2020 Tufts CSDD study examines relationship between investigative site personnel diversity and study participant diversity.
Latest:
eSource Interoperability Between EHR and EDCEvidence from a Phase III cancer trial points to notable advances in data-transfer tech.
Latest:
Real-World Use of an Artificial Intelligence-Supported Solution for Coding of Adverse Events in Clinical TrialsStudy evaluates the use of AI-supported medical coding module.
Latest:
Clinical Study Audits: The Quality Management ApproachAdvancing risk-based auditing one step further by identifying the underlying process deficiencies to enable improved corrective and preventive actions.
Latest:
Accelerating Clinical Trial Design and OperationsFully-integrated, component-based CDMS offers flexibility, customization, and efficiency.
Latest:
Transforming Clinical Event Adjudication in the Era of COVID-19There's no one-size-fits-all approach during the COVID-19 pandemic
Latest:
Where Do We Go From Here?Lessons from six months of conducting clinical trials during the COVID-19 pandemic
Latest:
Rethinking ECOG Scores to Improve Patient Access and Clinical Trials EligibilityRecent study results highlight need for new metrics in ECOG scoring to mitigate variability.
Latest:
How a Global Privacy Standard Can Boost Patient TrustRegulations that apply across geographic borders can provide researchers and patients a firmer foundation on data protection.
Latest:
Pivoting Toward Sustainable Supply Chains in Clinical ResearchAs clinical research continues to globalize and grow at pace, there is a risk that global greenhouse gas emissions will escalate unless mitigation strategies are actively included in corporate strategies.
